Your browser doesn't support javascript.
loading
The clinical efficacy of Rituximab administration in autoimmunity disorders, primary immunodeficiency diseases and malignancies.
Zian, Zeineb; Berry, S P Déo-Gracias; Bahmaie, Nazila; Ghotbi, Dana; Kashif, Ali; Madkaikar, Manisha; Bargir, Umair Ahmed; Abdullahi, Hamisu; Khan, Haroon; Azizi, Gholamreza.
Afiliación
  • Zian Z; Biomedical Genomics and Oncogenetics Research Laboratory, Faculty of Sciences and Techniques of Tangier, P.B. 416, Abdelmalek Essaadi University, Tetouan, Morocco.
  • Berry SPD; Centre de Recherches Médicales (CERMEL) de Lambaréné, B.P: 242, Gabon; Technical University of Munich, 80333, Germany.
  • Bahmaie N; Department of Allergy and Immunology, Faculty of Medicine, Graduate School of Health Science, Near East University (NEU), Nicosia, 99138, Northern Cyprus, Cyprus.
  • Ghotbi D; Faculty of Biological Sciences, University of Kharazmi, Tehran 14911-15719, Iran.
  • Kashif A; Department of Pharmacy, Abdul Wali Khan University, Mardan 23200, Pakistan.
  • Madkaikar M; Department of Pediatric Immunology and Leukocyte Biology, ICMR-National Institute of Immunohaematology, Mumbai 400070, India.
  • Bargir UA; Department of Pediatric Immunology and Leukocyte Biology, ICMR-National Institute of Immunohaematology, Mumbai 400070, India.
  • Abdullahi H; Department of Immunology, School of Medical Laboratory Sciences, Usmanu Danfodiyo University Sokoto, 840232, Nigeria.
  • Khan H; Department of Pharmacy, Abdul Wali Khan University, Mardan 23200, Pakistan.
  • Azizi G; Non-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj 3149779453, Iran. Electronic address: azizi@abzums.ac.ir.
Int Immunopharmacol ; 95: 107565, 2021 Jun.
Article en En | MEDLINE | ID: mdl-33773205

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Rituximab / Antineoplásicos Inmunológicos / Enfermedades de Inmunodeficiencia Primaria / Factores Inmunológicos / Trastornos Linfoproliferativos / Neoplasias Idioma: En Revista: Int Immunopharmacol Asunto de la revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedades Autoinmunes / Rituximab / Antineoplásicos Inmunológicos / Enfermedades de Inmunodeficiencia Primaria / Factores Inmunológicos / Trastornos Linfoproliferativos / Neoplasias Idioma: En Revista: Int Immunopharmacol Asunto de la revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Año: 2021 Tipo del documento: Article